CTOs on the Move

Illinois Knights Templar Home

www.ikth.com

 
Illinois Knights Templar Home is a Paxton, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ikth.com
  • 450 E Fulton St
    Paxton, IL USA 60957
  • Phone: 217.379.2116

Executives

Name Title Contact Details

Similar Companies

Lane Individual Practice Association

Lane Individual Practice Association is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AOS Research Services

AOS Research Services is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

United Ambulance

United Ambulance is a Lewiston, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tia

Founded in 2017 by Carolyn Witte and Felicity Yost, Tia is bringing the new standard of care for women for women in NY, LA, SF and PHX. Blending in-person and virtual care services, Tia`s “Whole Woman, Whole Life” care model fuses gynecology, primary care, mental health and evidence-based wellness services to treat women comprehensively. By bringing collaborative, comprehensive, and compassionate care, Tia is raising the bar for women and empowering them to achieve optimal health, on their terms.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.